(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 13.96% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Twist Bioscience's revenue in 2026 is $431,798,000.On average, 12 Wall Street analysts forecast TWST's revenue for 2026 to be $29,185,289,278, with the lowest TWST revenue forecast at $28,022,693,637, and the highest TWST revenue forecast at $30,090,157,406. On average, 12 Wall Street analysts forecast TWST's revenue for 2027 to be $34,790,078,835, with the lowest TWST revenue forecast at $32,256,698,906, and the highest TWST revenue forecast at $36,582,257,013.
In 2028, TWST is forecast to generate $40,015,488,477 in revenue, with the lowest revenue forecast at $35,728,808,972 and the highest revenue forecast at $43,364,064,919.